Trial NCT03736967

View at ClinicalTrials.gov 
Org. Study IDs: R3500-AD-1798
Secondary IDs: 2018-001543-30

Last trial update was posted on 2021-11-01

MeSH Interventions

Antibodies, Monoclonal

MeSH Conditions

Dermatitis Dermatitis, Atopic Eczema

Other Conditions

Atopic Dermatitis

Stopping Reasons

Lack of efficacy

Limitations And Caveats

The decision was made by the sponsor to terminate the study on 12 Feb 2020 due to lack of efficacy. Study enrollment was not complete at that time, therefore planned sample sizes were not met. Participants discontinued study drug and transitioned into the post-treatment follow-up period. As a result of the decision to terminate the study, all statistical analyses were descriptive and no hypothesis testing was performed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID